SCHEMBL4790476

SCHEMBL4790476

COc1ccc(OC)c(-c2cc(Nc3ccc(NC(=O)c4ccccc4)cc3)ncn2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.67
ERBB3 P21860 2/20 0.67
CDK9 P50750 9/20 0.57
CCNT1 O60563 7/20 0.57
ADORA3 P0DMS8 1/20 0.55
ABL1 P00519 2/20 0.55
BCR P11274 2/20 0.55
USP2 O75604 1/20 0.54
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
ALOX15 P16050 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
AURKB Q96GD4 2/20 0.53
AURKA O14965 1/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5734993 0.93 EGFR (0.68) EGFRERBB3CDK9CCNT1ADORA3
SCHEMBL4108197 0.90 EGFR (0.53) EGFRERBB3CDK9CCNT1ADORA3
SCHEMBL5733124 0.90 EGFR (0.58) EGFRERBB3CDK9CCNT1USP2
SCHEMBL4759000 0.90 CDK9 (0.70) EGFRERBB3CDK9CCNT1USP2
SCHEMBL5734587 0.88 EGFR (0.56) EGFRERBB3CDK9CCNT1USP2
SCHEMBL4116315 0.87 CDK9 (0.69) EGFRERBB3CDK9CCNT1USP2
SCHEMBL5732539 0.85 EGFR (0.76) EGFRERBB3ADORA3ABL1BCR
SCHEMBL4761482 0.84 CDK9 (0.59) EGFRERBB3CDK9CCNT1USP2
SCHEMBL5733999 0.83 EGFR (0.62) EGFRERBB3CDK9CCNT1ADORA3
SCHEMBL4098044 0.83 EGFR (0.54) EGFRERBB3CDK9CCNT1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1901747-A2 PYRIMIDINE-BASED CDK INHIBITORS FOR TREATING PAIN Ingenium Pharmaceuticals AG (DE) 2008-03-26 EP claimed
WO-2006125616-A2 PYRIMIDINE-BASED CDK INHIBITORS FOR TREATING PAIN INGENIUM PHARMACEUTICALS AG (DE) 2006-11-30 WO claimed